Fenofibrate tablets have an estimated market size of USD 100 million for twelve months ending September 2019, according to IQVIA.
Alembic Pharma gets final USFDA nod for Fenofibrate tablets
More from Industry NewsMore posts in Industry News »
- Bausch, Clearside receive U.S. approval for eye injection
- Priority list being drawn up of kids with comorbidities for vaccine rollout
- Namibia halts use of Sputnik jabs after South Africa HIV fears
- We are waiting for DCGI approval for children’s Covid-19 vaccine: Bharat Biotech Chairman
- Covid-19: ICMR and task force stress on completing adult vaccination